Trials / Sponsors / Elcelyx Therapeutics, Inc.
Elcelyx Therapeutics, Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Type 2 Diabetes Mellitus | Phase 2 | 2015-09-01 |
| Completed | Assessing the Behavior of Met DR in Subjects With Kidney Dysfunction Renal Insufficiency | Phase 2 | 2014-01-01 |
| Completed | Assessing the Efficacy, Safety, and Tolerability of Met DR in Subjects With T2DM Over 12 Weeks Type 2 Diabetes Mellitus | Phase 2 | 2013-04-01 |
| Completed | Assessing the Effect of Met DR on Plasma Glucose and PK in Subjects With T2DM Type 2 Diabetes Mellitus | Phase 1 / Phase 2 | 2012-12-01 |
| Completed | Assessing the PK of Met DR, Met IR, and Met XR in Healthy Subjects Healthy Subjects | Phase 1 | 2012-10-01 |
| Completed | Assessing the PK and Effect on Glucose and GI Hormone Concentrations of Metformin Delayed-Release in Subjects Type 2 Diabetes Mellitus | Phase 1 / Phase 2 | 2012-05-01 |